IN2012DN04939A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN04939A IN2012DN04939A IN4939DEN2012A IN2012DN04939A IN 2012DN04939 A IN2012DN04939 A IN 2012DN04939A IN 4939DEN2012 A IN4939DEN2012 A IN 4939DEN2012A IN 2012DN04939 A IN2012DN04939 A IN 2012DN04939A
- Authority
- IN
- India
- Prior art keywords
- drug
- core
- skin
- polymer
- skins
- Prior art date
Links
- 239000003814 drug Substances 0.000 abstract 8
- 229940079593 drug Drugs 0.000 abstract 8
- 229920000642 polymer Polymers 0.000 abstract 4
- 238000000576 coating method Methods 0.000 abstract 2
- 238000002347 injection Methods 0.000 abstract 2
- 239000007924 injection Substances 0.000 abstract 2
- 238000013270 controlled release Methods 0.000 abstract 1
- 238000012377 drug delivery Methods 0.000 abstract 1
- 239000013583 drug formulation Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000006193 liquid solution Substances 0.000 abstract 1
- 239000006194 liquid suspension Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
An injectable drug delivery device includes a core containing one or more drugs and one or more polymers. The core may be surrounded by one or more polymer outer layers (referred to herein as 'coatings,' 'skins,' or 'outer layers'). In certain embodiments, the device is formed by extruding or otherwise preforming a polymeric skin for a drug core. The drug core may be co-extruded with the skin, or inserted into the skin after the skin has been extruded, and possibly cured. In other embodiments, the drug core may be coated with one or more polymer coatings. These techniques may be usefully applied to fabricate devices having a wide array of drug formulations and skins that can be selected to control the release rate profile and various other properties of the drugs in the drug core in a form suitable for injection using standard or non-standard gauge needles. The device may be formed by combining at least one polymer, at least one drug, and at least one liquid solvent to form a liquid suspension or solution wherein, upon injection, such suspension or solution under goes a phase change and forms a gel. The configuration may provide for controlled release of the drug(s) for an extended period.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92587603A | 2003-11-13 | 2003-11-13 | |
| US54336804P | 2004-02-09 | 2004-02-09 | |
| PCT/US2004/035430 WO2005051234A2 (en) | 2003-11-13 | 2004-10-26 | Injectable sustained release implant having a bioerodible matrix core and a bioerodible skin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN04939A true IN2012DN04939A (en) | 2015-09-25 |
Family
ID=54398537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN4939DEN2012 IN2012DN04939A (en) | 2003-11-13 | 2004-10-26 |
Country Status (1)
| Country | Link |
|---|---|
| IN (1) | IN2012DN04939A (en) |
-
2004
- 2004-10-26 IN IN4939DEN2012 patent/IN2012DN04939A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1114947T1 (en) | ADVANCED RELEASED REFRESHMENT INFECTION PROVIDED WITH A KIND OF BIOGRADE MATTER AND A BIOGRADE LEATHER | |
| DE69929055T2 (en) | METHOD FOR THE INJECTION MOLDING OF DEVICES WITH CONTROLLED ACTIVE INGREDIENT RELIEF AND DEVICE MADE THEREFOR | |
| ATE349202T1 (en) | HEPARIN, GLYCOSAMINOGLYCAN OR HEPARINOID-BASED FORMULATION AND USE OF THE FORMULATION AND THE FORMULATION BASE | |
| WO2008139786A1 (en) | Microneedle device and method for producing the same | |
| DK1372729T3 (en) | Degradable polymers for injection | |
| NZ600921A (en) | Intraocular drug delivery systems | |
| WO2007041410A3 (en) | Sustained release small molecule drug formulation | |
| WO2011012137A3 (en) | A medical device of polyolefin | |
| ES2093625T3 (en) | EXTENDED PHARMACEUTICAL ADMINISTRATION OF SMALL MOLECULES SOLUBLE IN WATER. | |
| PL1687049T3 (en) | Syringes, syringe interfaces and syringe plungers for use with medical injectors | |
| MXPA05003919A (en) | Method and device for manufacturing plungers for medical syringes, plungers obtained thereby, as well as a syringe for medical purposes. | |
| DE60022332D1 (en) | KETOPROFEN MICROGRANULATE, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS | |
| ATE398447T1 (en) | USE OF ETHANOL AS A PLASTICIZER FOR THE PRODUCTION OF SUBCUTANEOUS IMPLANTS, WHICH CONTAIN THERMOLABILITY ACTIVE INGREDIENTS DISPERSED IN A PLGA MATRIZE | |
| WO2012044351A3 (en) | Composite polymeric flowforming with x-y translating mold base | |
| PT840583E (en) | TUBULAR BODY FOR TUBE APPLICATORS AND METHOD FOR THEIR MANUFACTURE FROM A SOFT AND FLEXIBLE COMPOSITION | |
| US20240277907A1 (en) | Compositions of extended release coatings and methods for applying extended release coatings | |
| EP2072216A3 (en) | Manufacturing method and apparatus of optical goods | |
| CN223641172U (en) | Accurate ware of dosing of skin external medicine | |
| CL2025003034A1 (en) | Drug delivery system and methods of use. | |
| PH12022550653A1 (en) | Aerosol-generating element for use in an aerosol-generating article or system | |
| EP1847279A3 (en) | Drug delivery via conformal film |